Antibody Drug Boosts Survival for Type of Advanced Breast Cancer
THURSDAY, Dec. 8, 2022 (HealthDay News) — A relatively new drug is boosting survival rates for women with a specific type of advanced breast cancer who haven’t responded to other treatments, according to a pair of clinical trials. The targeted antibody drug — trastuzumab deruxtecan (T-DXd, sold under the brandContinue Reading